8-K
Current Report
Adaptimmune Therapeutics PLC Filed Acc 0001558370-23-002829
Agreement ended · Results of operations · Executive or director change
- Item 1.02 Termination of a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading adap-20230302x8k.htm…